Patent · US Active

Multispecific antibodies that target HIV GP120 and CD3

US11597759B2 · kind B2 · utility

2Cited by
26References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 6, 2020
Grant dateMar 7, 2023
Priority date—
Expiry dateMay 6, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Multispecific antibodies (e.g., bispecific antibodies) that bind to HIV gp120 and CD3 are disclosed. Also disclosed are methods of using such antibodies to treat or prevent HIV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.